Clinical Trials Sponsored by Zuun Kharaa Hospital

Total 343 results

Brigham and Women's Hospital
National Center for Maternal and Child Health Research, Mongolia; Zuun Kharaa...

Completed

Trial of Vitamin D Supplements to Raise Calcidiol Levels of Pregnant Women in Mongolia

Vitamin D Deficiency | Pregnancy

Mongolia
Leslie Zun, MD
Teva Pharma

Unknown

Self Reported Level of Agitation of Patients Presenting to an Emergency Department

Psychiatric Issue

United States
Oznur Uzun

Recruiting

Comparative Evaluation of the Results of Facet Joint Injections

Low Back Pain, Mechanical | Facet Syndrome of Lumbar Spine

Turkey
Asarina Pharma
Herlev Hospital

Completed

A Study to Explore the Effect of Sepranolone in Tourette Syndrome

Tourette Syndrome | Tourette Syndrome in Adolescence

Denmark
Butler Hospital
UCB Pharma

Completed

Effectiveness of Levetiracetam in the Treatment of Body Dysmorphic Disorder

Body Dysmorphic Disorder

United States
Hospital Aleman
Vifor Pharma

Completed

Switch From Oral Iron to Intravenous Ferric Carboxymaltose in Non-dialysis Chronic Kidney Disease (CKD)

Iron Deficiency | Anaemia

Argentina
RenJi Hospital
AbelZeta Pharma Inc.

Recruiting

A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy (CAR-AID)

Systemic Lupus Erythematosus (SLE) | Neuromyelitis Optica Spectrum Disorders | Immune-Mediated Necrotizing Myopathy | Multiple Sclerosis-Relapsing-Remitting

China
University Hospital Muenster
Vifor Pharma

Terminated

Intravenous Ferric Carboxymaltose (Ferinject) in Patients Undergoing Orthopaedic Surgery (PRIVIRON)

Anemia | Orthopedic Surgery | High Risk of Blood Loss

Germany
Rennes University Hospital
Innate Pharma

Terminated

Immunotherapy of Hepatocellular Carcinoma With Gamma Delta T Cells (ICAR)

Hepatocellular Carcinoma

France
University Hospital, Grenoble
NETRIS Pharma

Recruiting

Study Investigating the Association of NP137 With mFOLFIRINOX in Locally Advanced Pancreatic Ductal Adenocarcinoma (LAP-NET1)

Pancreatic Ductal Adenocarcinoma

France
University Hospital, Grenoble
Genoscience Pharma

Recruiting

Ezurpimtrostat Autophagy Inhibitor in Association With Atezolizumab-Bevacizumab in First Line Treatment of Unresectable Hepatocellular Carcinoma (ABE-LIVER)

Hepatocellular Carcinoma

France
University Hospital, Lille
InBrain Pharma

Recruiting

Dopaminergic restauratIon by intraVEntriculaire Administration (DIVE)

Parkinson Disease

France
Rennes University Hospital
H.A.C. PHARMA

Suspended

Hemodynamics Effects of Fludrocortisone on the Pressor Response to Noradrenaline Septic Shock Patients (FLUDROSEPSIS)

Septic Shock

France
University Hospital, Ghent
UCB Pharma

Completed

Zilucoplan® in Improving Oxygenation, Short-, Longterm Outcome of COVID19 Patients With Acute Hypoxic Respiratory Failure (ZILU-COV)

COVID-19

Belgium
University Hospital, Ghent
UCB Pharma

Withdrawn

Sodium Oxybate in Patients With Chronic Fatigue Syndrome.

Chronic Fatigue Syndrome

Belgium
Aarhus University Hospital
LEO Pharma

Unknown

Effect of Brodalumab Compared to Placebo on Vascular Inflammation in Moderate-to-severe Psoriasis

Psoriasis

Denmark
Hvidovre University Hospital
Zealand Pharma

Completed

Study of Immune Cells in Obese Patients With Type 2 Diabetes Mellitus Treated With Liraglutide

Type 2 Diabetes Mellitus

Denmark
Hartford Hospital
Astellas Pharma Inc

Completed

Regadenoson Combined With Symptom-Limited Exercise in Patients Undergoing Myocardial Perfusion Imaging

Myocardial Ischemia | Coronary Artery Disease

United States
Massachusetts General Hospital
UCB Pharma

Withdrawn

Seizure Therapy With Intravenous Levetiracetam and Lorazepam (STILL)

Seizures
Rennes University Hospital
UCB Pharma

Terminated

Prevention of Post-traumatic Seizures With Levetiracetam (TRACK)

Epilepsy, Post-Traumatic

France
Oslo University Hospital
Pharma Nord

Completed

The Effect of Q10 and Selen Supplement on Muscular Adverse Events in Statin Therapy

Statin Therapy

Norway
Nantes University Hospital
LEO Pharma

Not yet recruiting

Ophthalmological Adverse Events of Tralokinumab in AD (TRALO-Oeil)

Atopic Dermatitis

France
University Hospital, Grenoble
NETRIS Pharma

Recruiting

Study Investigating the Association of NP137 With Atezolizumab-Bevacizumab Combination in First Line in Unresectable HCC (Liver-NET1)

Hepatocellular Carcinoma

France
Turku University Hospital
Vifor Pharma

Recruiting

Preoperative Intravenous Ferric Carboxymaltose and Placebo in the Treatment of Patients Undergoing Cardiac Surgery (PREFER-CABG)

Coronary Artery Disease | Postoperative Complications | Aortic Valve Stenosis | Aortic Aneurysm, Thoracic | Mitral Valve Disease

Finland
Ruijin Hospital
Chugai Pharma China

Completed

Different Anti-Spastic Therapy Strategies After CABG Using Radial Artery Grafts (ASRAB-Pilot)

Coronary Artery Bypass Graft | Radial Artery Grafts | Antispastic Therapy | Pilot Study

China
Xijing Hospital
Roche Pharma AG

Unknown

Metronomic Chemotherapy of Capecitabine After Standard Adjuvant Chemotherapy in Operable Triple Negative Breast Cancer (MACRO)

Breast Cancer | Triple Negative Breast Cancer | Capecitabine

China
Hartford Hospital
Astellas Pharma Inc

Terminated

Clinical Trial of Solifenacin Versus Placebo Plus Pessary for Women With Vaginal Prolapse (PESSARY)

Pelvic Organ Prolapse

United States
University Hospital, Geneva
Bayer; AstraZeneca; Vifor Pharma; Labatec Pharma SA

Terminated

Improving Knowledge in Heart Failure Inpatient With Therapeutic Education (EDUC-IC)

Medication Adherence | Knowledge, Attitudes, Practice | Heart Failure With Reduced Ejection Fraction | Pharmacist-Patient Relations | Heart Failure; With Decompensation

Switzerland
Central Hospital, Nancy, France
UCB Pharma

Not yet recruiting

Digital Solution to Improve Cognitive Function in Epilepsy: PRODDIGE Project (PRODDIGE)

Cognitive Change
University Hospital, Gentofte, Copenhagen
Zealand Pharma

Completed

GIP/GLP-1 Co-Activity in Subjects With Overweight and Type 2 Diabetes: Lowering of Food Intake (GASOLIN II)

Type 2 Diabetes Mellitus | Overweight and Obesity

Denmark
University Hospital, Ghent
Roche Pharma AG

Completed

Individually Adapted Immunosuppression in de Novo Renal Transplantation Based on Immune Function Monitoring: a Prospective Randomised Study (CD4-01)

Kidney Transplantation

Belgium
Hvidovre University Hospital
Moberg Pharma, Sweden

Completed

Local Anesthetic Treatment of Oral Pain in Patients With Mucositis

Mucositis

Denmark
Ottawa Hospital Research Institute
LEO Pharma

Completed

Thromboprophylaxis for Patients Undergoing Surgical Resection for Colon Cancer (PERI-OP)

Cancer | Deep Vein Thrombosis | Pulmonary Embolism

Canada
Ottawa Hospital Research Institute
LEO Pharma

Completed

A Comparison of Dalteparin and Tinzaparin for Prevention of Blood Clots in Hemodialysis Patients on Oral Anticoagulants Having Surgery

Hemodialysis | Thromboembolism

Canada
University Hospital, Bordeaux
IPSEN PHARMA S.A.S

Completed

Restless Legs Syndrome Treatment With Botulinum Toxin (SOXIS)

Restless Legs Syndrome

France
University Hospital Heidelberg
Roche Pharma AG

Recruiting

Predicting Response to Neoadjuvant ATEZOLIZUMAB Plus Carboplatin/Nab Paclitaxel in Resectable Non-squamous NSCLC (iReP)

NSCLC Stage IIIB | NSCLC Stage II | NSCLC, Stage IIIA

Germany
Septodont
Rennes University Hospital; Slb Pharma

Completed

Gingival Displacement With RACESTYPTINE Solution and RACEGEL: a Prospective, Comparative Randomized Clinical Trial. (RETRACT)

Gingival Retraction Techniques

France
Massachusetts General Hospital
Astellas Pharma Inc

Completed

A Pilot Study Evaluating the Usability of the Oabi Mobile Application (OAB)

Overactive Bladder

United States
University Hospital, Ghent
UCB Pharma SA

Completed

Scintigraphic Detection of the Biodistribution of Tumor Necrosis Factor With a Radiolabeled Anti-TNFα in Patients With Active Rheumatoid Arthritis and Active Axial and Peripheral Spondyloarthritis (SCINTRA)

Rheumatoid Arthritis | Axial and Peripheral Spondyloarthritis

Belgium
University Hospital, Tours
Roche Pharma AG

Completed

Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal Transplantation (RITUX-ERAH)

Humoral Rejection in Kidney Transplantation

France
Ottawa Hospital Research Institute
LEO Pharma

Completed

The STOP CLOT Pilot Study: Study of Low Molecular Weight Heparin in High Risk Cesarean Section

Deep Vein Thrombosis

Canada
Rennes University Hospital
Roche Pharma AG

Completed

Molecular Diagnosis on Circulating Tumor DNA of Non-Small Cell Lung Cancer (ANTiCIPe)

Stage IIIb and IV Non Small Cell Lung Cancer

France
Cantonal Hospital, Frauenfeld
Astellas Pharma Inc

Completed

Therapy of the Overactive Bladder Syndrome (TOBS)

Overactive Bladder

Switzerland
Mackay Memorial Hospital
OBI Pharma, Inc

Unknown

Trial of Active Immunotherapy With Globo H-KLH (OPT-822/821) in Women Who Have Non-Progressive Ovarian Cancer

Ovarian Cancer

Taiwan
University Hospital, Tours
Astellas Pharma Inc

Unknown

Efficacy and Safety Study of a 4-Month Post-Renal Transplant Dose Reduction of Tacrolimus(ADEQUATE) (ADEQUATE)

De Novo Transplant Disease

France
University Hospital, Ghent
Astellas Pharma Inc

Completed

The Effect of Magnesium on Early Post-transplantation Glucose Metabolism

Glucose Metabolism After Transplantation

Belgium
University Hospital, Tours
Roche Pharma AG

Unknown

Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal Transplantation (RITUX-ERAH)

Graft Rejection

France
University Hospital, Grenoble
Roche Pharma AG

Completed

Preliminary Administration of EPO and Markers of Cardiac Ischemia Induced by CPB (EPOetCEC)

Myocardial Ischemia

France
University Hospital, Ghent
Nordic Pharma SAS

Recruiting

Prevention of Intra-uterine Adhesions Following Laparoscopic and Laparotomic Myomectomy (PALLM)

Myoma

Belgium
Seoul National University Hospital
Vifor Pharma

Not yet recruiting

Effect of Preoperative Intravenous Ferric Carboxymaltose for Clipping Surgery (PICASA)

Surgery | Iron Deficiency Anemia | Cerebral Aneurysm Unruptured

Clinical Trials Sponsored by Zuun Kharaa Hospital

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Iran

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations